Today, the diagnosis of definite AD requires clinical diagnosis, based on the observation of clinical symptoms, and postmortem detection of amyloid plaques and neurofibrillary tangles, the latter composed of aggregated tau protein, in the brain tissue of the deceased patient. Here, MAPT is linked to Alzheimer disease.